Eltrombopag
Generic Name: eltrombopag
Brand Names:
Eltrombopag Olamine
Eltrombopag is a thrombopoietin receptor agonist available as film-coated tablets in 12.5 mg, 25 mg, 50 mg, and 75 mg strengths.
Overview
Eltrombopag is a thrombopoietin receptor agonist available as film-coated tablets in 12.5 mg, 25 mg, 50 mg, and 75 mg strengths.
Uses
Indicated for treating thrombocytopenia in three contexts: persistent/chronic immune thrombocytopenia (ITP) in patients 1+ years, chronic hepatitis C-associated thrombocytopenia, and severe aplastic anemia in patients 2+ years.
Dosage
Initial dosing varies by indication: 50 mg daily for ITP (adults/pediatric 6+), 25 mg daily for hepatitis C, and 150 mg daily for first-line aplastic anemia (patients 12+).
Side Effects
Most common include anemia, nausea, pyrexia, alanine aminotransferase increased, cough, fatigue, headache, and diarrhea.
Interactions
Chelation with polyvalent cations. Transporter interactions with specific medications.
Warnings
BOXED WARNING: Risk of hepatic decompensation in chronic hepatitis C patients and hepatotoxicity risk with regular function monitoring. Hepatotoxicity, increased MDS progression risk, thrombotic complications, and cataracts require monitoring.
Pregnancy
Animal studies showed embryolethality at doses 6x human exposure. Insufficient human data available.
Frequently Asked Questions
What is Eltrombopag used for?▼
Indicated for treating thrombocytopenia in three contexts: persistent/chronic immune thrombocytopenia (ITP) in patients 1+ years, chronic hepatitis C-associated thrombocytopenia, and severe aplastic anemia in patients 2+ years.
What are the side effects of Eltrombopag?▼
Most common include anemia, nausea, pyrexia, alanine aminotransferase increased, cough, fatigue, headache, and diarrhea.
Can I take Eltrombopag during pregnancy?▼
Animal studies showed embryolethality at doses 6x human exposure. Insufficient human data available.
What are the important warnings for Eltrombopag?▼
BOXED WARNING: Risk of hepatic decompensation in chronic hepatitis C patients and hepatotoxicity risk with regular function monitoring. Hepatotoxicity, increased MDS progression risk, thrombotic complications, and cataracts require monitoring.
Related Medications
Echinacea, Hydrastis Canadensis, Hypericum Perforatum, Symphytum Officinale, Apis Mellifica, Arnica Montana, Bellis Perennis, Bryonia, Calendula Officinalis, Chamomilla, Cinchona Officinalis, Gelsemium Sempervirens, Hamamelis Virginiana, Hypericum Perforatum, Lacticum Acidum, Ledum Palustre, Phosphorus, Rhus Toxicodendron, Ruta Graveolens, Sarcolacticum Acidum, Staphysagria, Symphytum Officinale
echinacea, hydrastis canadensis, hypericum perforatum, symphytum officinale, apis mellifica, arnica montana, bellis perennis, bryonia, calendula officinalis, chamomilla, cinchona officinalis, gelsemium sempervirens, hamamelis virginiana, hypericum perforatum, lacticum acidum, ledum palustre, phosphorus, rhus toxicodendron, ruta graveolens, sarcolacticum acidum, staphysagria, symphytum officinale
Standardized Insect Venom Allergenic Extract [EPC]
OTC - PURPOSE SECTION Formulated for workout recovery and for symptoms associated with injury, overexertion and emotional distress.
Fluvastatin Sodium Unmilled
fluvastatin sodium unmilled
Dosage form: POWDER. Active ingredients: FLUVASTATIN SODIUM (1 kg/kg). Category: BULK INGREDIENT.
Danil Compound Ketoconazole Solution For Scalp Disorders.
danil compound ketoconazole solution for scalp disorders.
Azole Antifungal [EPC]
PHARMACOLOGICAL ACTION: In vitro, DANIL solution exhibits a potent antimycotic activity. In vivo studies in animal patterns infected with superficial fungi, it is shown that DANIL solution has an excellent therapeutic effect, especially for that caused by Pityrosporum oval. Combined with Clobetasol propionate, a potent anti-inflammatory and anti-pruritic topical corticosteroid agent, DANIL solution has the actions of anti-bacterial, anti-inflammatory, anti-allergic, anti-dandruff and anti-prurit
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.